000 01475 a2200385 4500
005 20250512042207.0
264 0 _c19890323
008 198903s 0 0 eng d
022 _a0888-8809
024 7 _a10.1210/mend-2-11-1132
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHinkle, P M
245 0 0 _aCalcium channel agonists and antagonists: effects of chronic treatment on pituitary prolactin synthesis and intracellular calcium.
_h[electronic resource]
260 _bMolecular endocrinology (Baltimore, Md.)
_cNov 1988
300 _a1132-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCalcium
_xanalysis
650 0 4 _aCalcium Channel Agonists
_xpharmacology
650 0 4 _aCalcium Channel Blockers
_xpharmacology
650 0 4 _aDihydropyridines
_xpharmacology
650 0 4 _aPituitary Gland
_xanalysis
650 0 4 _aPituitary Neoplasms
_xmetabolism
650 0 4 _aProlactin
_xbiosynthesis
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aRats
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aJackson, A E
700 1 _aThompson, T M
700 1 _aZavacki, A M
700 1 _aCoppola, D A
700 1 _aBancroft, C
773 0 _tMolecular endocrinology (Baltimore, Md.)
_gvol. 2
_gno. 11
_gp. 1132-8
856 4 0 _uhttps://doi.org/10.1210/mend-2-11-1132
_zAvailable from publisher's website
999 _c3227659
_d3227659